Clinical Trials Directory

Trials / Completed

CompletedNCT01067248

Chronic Obstructive Pulmonary Disease (COPD) and Osteoporosis

Patho-physiology of Osteoporosis in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Catharina Ziekenhuis Eindhoven · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The main objective is to study important factors in the patho-physiology of osteoporosis in patients with COPD. Therefore, the investigators will study biological markers in plasma and urine and correlate them to markers of bone turnover and clinical data.

Detailed description

Rationale: Chronic obstructive pulmonary disease (COPD) is defined as a preventable and treatable disease with significant extrapulmonary effects. Osteoporosis is recognized as one of these extrapulmonary consequences. It results in increased risk of fracture and thereby an increased morbidity and mortality. Nowadays it is believed that the patho-physiology of osteoporosis is multi-factorial. However, which factors are most important in patients with COPD is still not clear. Objective: The main objective is to study important factors in the patho-physiology of osteoporosis in patients with COPD. Therefore, we will study biological markers in plasma and urine and correlate them to markers of bone turnover and clinical data. Study design: The present study will be an observational, cross-sectional study.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2010-02-11
Last updated
2015-07-29

Source: ClinicalTrials.gov record NCT01067248. Inclusion in this directory is not an endorsement.